How Do I Examine Laryngeal Dystonia?
- PMID: 38962902
- PMCID: PMC11329560
- DOI: 10.1002/mdc3.14131
How Do I Examine Laryngeal Dystonia?
Abstract
Laryngeal dystonia is a potentially disabling task specific dystonia primarily affecting speech. The evaluation and diagnosis of laryngeal dystonia remain challenging, and often require a multi-disciplinary approach, involving collaboration among speech language pathologists, neurologists and laryngologists (1-5). It is crucial to correctly differentiate between the types of laryngeal dystonia due to the distinct therapeutic approaches and responses to botulinum toxin therapy or speech therapy. For educational purposes, we have divided laryngeal dystonia into two main types: adductor and abductor dystonia. In this article, we describe a series of examination techniques that can assist movement disorders neurologists diagnosing this condition, and appropriately differentiating the most common forms of laryngeal dystonia.
Keywords: laryngeal dystonia; speech disorders; task‐specific dystonia.
© 2024 International Parkinson and Movement Disorder Society.
Similar articles
-
Botulinum toxin type A therapy for cervical dystonia.Cochrane Database Syst Rev. 2017 Dec 12;12(12):CD003633. doi: 10.1002/14651858.CD003633.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Nov 12;11:CD003633. doi: 10.1002/14651858.CD003633.pub4. PMID: 29230798 Free PMC article. Updated.
-
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.Cochrane Database Syst Rev. 2016 Oct 26;10(10):CD004314. doi: 10.1002/14651858.CD004314.pub3. Cochrane Database Syst Rev. 2016. PMID: 27782297 Free PMC article.
-
Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.Neurotox Res. 2012 Nov;22(4):265-73. doi: 10.1007/s12640-012-9314-y. Epub 2012 Feb 23. Neurotox Res. 2012. PMID: 22359151
-
Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value.J Neurol. 2012 Dec;259(12):2519-26. doi: 10.1007/s00415-012-6510-x. Epub 2012 May 3. J Neurol. 2012. PMID: 22552527 Free PMC article.
-
Botulinum toxin type B for cervical dystonia.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004315. doi: 10.1002/14651858.CD004315.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2016 May 13;(5):CD004315. doi: 10.1002/14651858.CD004315.pub3. PMID: 15674941 Updated.
References
-
- Stewart CF, Allen EL, Tureen P, Diamond BE, Blitzer A, Brin MF. Adductor spasmodic dysphonia: standard evaluation of symptoms and severity. J Voice 1997;11(1):95–103. - PubMed
-
- Rusz J, Tykalova T, Ramig LO, Tripoliti E. Guidelines for speech recording and acoustic analyses in dysarthrias of movement disorders. Mov Disord 2021;36(4):803–814. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources